We would love to hear your thoughts about our site and services, please take our survey here.
Going to be exciting Monday, two price monitoring extensions and counting......
Just voted - Remember to vote ‘YES’ to both parts of vote existing holders, you haven’t long to do it
Me neither, definitely a hold.
Yes it goes up and down dramatically, but think it’s got a way to go yet. I’m not in, I’m waiting hoping for the cycle to continue. It’s a great company and am sure will come good again so waiting for an entry
No news as yet. Was a timetable of events up to the general meeting which was on 23 July. All motions were passed, so just a matter of waiting now, imagine quite a lot to be sorted out and possibly further acquisitions are on the cards. Personally I’m thinking September is a possibility.
I’d be looking for sub 100 to get in at the moment, too much down side still
Good to see progress being made, a top deal. Obviously he still has huge ambitions and there will be more to come, thinking this will be huge.
Derriston not derision
When the suspension is lifted derision name won’t exist, it will be S4 capital
Was just a blip in the figures while suspended made me jump lol
Thought this was suspended? iii showing a buy/sell price again
Front page leading article in the Evening Standard Business pages
https://www.businessinsider.com.au/sir-martin-sorrell-wpp-derriston-capital-s4-capital-2018-5 Interesting read and possible deals mentioned
Excellent some news. Been sitting on these ages think it�s going to get exciting
Looking good here, couple of big director buys shows confidence
Paul Curtis is a private investor who targets what he sees to be bargains being a large share holder in many companies. Below is an example of an article which mentions him. Paul Curtis, the activist private investor who targets cash-rich distressed companies, has picked up his first notifiable holding at troubled stem cell research company Reneuron Holdings. Curtis has built a 1.25 million share holding though his George House Holdings, equivalent to 3.48% of the tiny �1.3 million company (REN) which stands unchanged on 3.5p today. When we spoke to Curtis yesterday he confirmed he bought the shares 'a few days ago.' He said: 'I bought it for the discount to cash, I hope there is up to 12p a share of cash or even perhaps a little more than that. It has an horrendous burn rate but I bought because I am confident the management will act, whether it be to liquidate and return cash or raise more. It's just a punt.' At the end of March last year Reneuron declared cash reserves of �8.8 million which were to last through to the end of this year or early 2004. Reneuron became Europe's first quoted stem cell research company in late 2000 and came to Citywire's attention when we revealed the Privy Purse, the vehicle for the Queen's personal investments, had taken a stake in the company. It is unclear whether she still holds any shares. If Her Majesty had held on to shares she would be cursing now as worries over funding and the recent failure of a pain drug in clinical trials have hit the share price. The pain drug was an early development ahead of its main objective of developing a treatment for neuro-disorders such as Parkinson's using the stem cells of aborted foetuses. When we spoke to Michael Hunt, Reneuron's finance director, about Curtis' purchase he said: 'We do not know the reasons for his buying but with the share price fall people can see an opportunity whatever endgame they are pursuing'
Reasonable write up in SCSW last time so becoming increasingly tempting now
Here's contact details of Harry's PA at Nexus group PA, Alanda Board: 0207 451 7056 Email: Alanda.board@nexusgroup.co.uk
Hi there. I wouldn't be surprised to hear something beginning of January as 22 Dec was a month since the director buy and xmas to new year isn't a good time to announce news. If they are asking for an extension come January I would expect no issues as there are some major investors/institutions in this and am sure any delay is down to waiting a great opportunity and getting an amazing deal sorted out.